Cleared Traditional

K053151 - RUBICOR MAGIC BREAST BIOPSY DEVICE

K053151 is an FDA 510(k) clearance for RUBICOR MAGIC BREAST BIOPSY DEVICE, manufactured by Rubicor Medical, Inc.. The device is a Class 2 Gastroenterology & Urology device with product code KNW cleared through the Traditional 510(k) pathway after a 8-day FDA review.

K053151 · Rubicor Medical, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2005
Decision
8d
Days
Class 2
Risk

K053151 is an FDA 510(k) clearance for the RUBICOR MAGIC BREAST BIOPSY DEVICE. Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by Rubicor Medical, Inc. (Redwood City, US). The FDA issued a Cleared decision on November 18, 2005 after a review of 8 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Rubicor Medical, Inc. devices

FDA 510(k) Submission Details - K053151

510(k) Number K053151 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 10, 2005
Decision Date November 18, 2005
Days to Decision 8 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
123d faster than avg
Panel avg: 131d · This submission: 8d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

KNW Device Classification - Class 2, Special Controls

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
MORTEN SIMON CHRISTENSEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KNW Instrument, Biopsy

All 306
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K053151.
CORAMATE/SPIROTOME SYSTEM
K060384 · Medinvents · Jul 2006
I-STYLE BONE MARROW ASPIRATION NEEDLE
K061570 · Busse Hospital Disposables, Inc. · Jul 2006
INTACT BREAST LESION EXCISION SYSTEM AND ADVANCE
K060413 · Intact Medical Corporation · Apr 2006
ABBOTT SPINE, INC. SPINNAKER SYSTEM
K052638 · Abbott Spine, Inc. · Nov 2005
PNEUMRX FAMILY OF BIOPSY NEEDLES AND KITS
K052435 · Pneumrx, Inc. · Nov 2005
MANAN BIO-CUT SOFT TISSUE BIOPSY NEEDLE
K052802 · Manan Medical Products, Inc. · Nov 2005

FDA 510(k) Resources - Gastroenterology & Urology

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.